CAS: 145375-43-5 - 2H-Isoindole-2-butanoic acid, octahydro-γ-oxo-α-(phenylmethyl)-, (αS,3aR,7aS)-
Formula:C19H25NO3
InChI:InChI=1S/C19H25NO3/c21-18(20-12-15-8-4-5-9-16(15)13-20)11-17(19(22)23)10-14-6-2-1-3-7-14/h1-3,6-7,15-17H,4-5,8-13H2,(H,22,23)/t15-,16+,17-/m0/s1
InChI key:InChIKey=WPGGHFDDFPHPOB-BBWFWOEESA-N
SMILES:O=C(O)C(CC=1C=CC=CC1)CC(=O)N2CC3CCCCC3C2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Mitiglinide REF: 4Z-M-501CAS: 145375-43-5 | - - - | To inquire | Fri 20 Dec 24 |
 | Mitiglinide REF: TM-T21431CAS: 145375-43-5 | - - - | 1,437.00 €~2,364.00 € | Fri 20 Dec 24 |
 | Mitiglinide REF: 3D-FM40715CAS: 145375-43-5 | Min. 95% | To inquire | Fri 24 Jan 25 |
Ref: 4Z-M-501
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Friday 20 Dec 2024
Mitiglinide
CAS:145375-43-5
Mitiglinide (KAD-1229), an insulinotropic ATP-sensitive K+ channel antagonist, targets Kir6.2/SUR1; used in type 2 diabetes …
Formula:
C19H25NO3
Color and Shape:
Solid
Molecular weight:
315.41
Ref: TM-T21431
| 25mg | 1,437.00 € | ||
| 50mg | 1,872.00 € | ||
| 100mg | 2,364.00 € |
Estimated delivery in United States, on Friday 20 Dec 2024
Mitiglinide
CAS:145375-43-5
Voltage-dependent K+ channel opener; insulinotropic sulfonylurea receptor ligand
Purity:
Min. 95%
Ref: 3D-FM40715
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Friday 24 Jan 2025
